Through cross-functional collaboration, continuous improvement, and sustainable practices, NTC earned the EcoVadis Committed Badge, a recognition that reflects the company's ongoing efforts to strengthen its sustainability performance and responsible business practices.

While crucial for health and longevity, large volumes and poor palatability discourage patients, so NTC completed studies on Kleerkol® to make this step easier, more tolerable, and to reduce reluctance to colonoscopy improving compliance to screening program.

NTC strenghtens its position in Italy by introducing an aflibercept biosimilar, expanding treatment access for neovascular retinal diseases and its product portfolio.

NTC has obtained MDR certification for 20 medical devices, strengthening the value of its portfolio and safeguarding access to the European market.